REG - PureTech Health PLC - Transaction in Own Shares
27/10/2023 07:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231027:nRSa4665Ra&default-theme=true
RNS Number : 4665R PureTech Health PLC 27 October 2023
27 October 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 26 October 2023
Number of ordinary shares purchased: 44,415
Highest price paid per share: 163.80p
Lowest price paid per share: 155.60p
Volume weighted average price paid per share: 158.31p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 15,833,651 ordinary
shares in treasury and has 273,634,508 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,634,508 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
26/10/2023 08:05:15 98 163.2 XLON 00375467329TRLO0.1.1
26/10/2023 08:27:18 409 163.8 XLON 00375472365TRLO0.1.1
26/10/2023 08:27:18 200 163.4 AQXE 00375472366TRLO0.1.1
26/10/2023 08:27:56 116 163.2 BATE 00375472435TRLO0.1.1
26/10/2023 08:27:56 256 163.2 BATE 00375472436TRLO0.1.1
26/10/2023 08:27:56 29 163.2 BATE 00375472437TRLO0.1.1
26/10/2023 08:27:59 37 162.2 TRQX 00375472440TRLO0.1.1
26/10/2023 08:35:31 507 162.2 XLON 00375473650TRLO0.1.1
26/10/2023 08:35:31 507 162.2 XLON 00375473651TRLO0.1.1
26/10/2023 08:35:31 7 162.2 TRQX 00375473652TRLO0.1.1
26/10/2023 08:35:31 50 162.2 TRQX 00375473653TRLO0.1.1
26/10/2023 08:35:32 3 160.6 CHIX 00375473654TRLO0.1.1
26/10/2023 09:37:38 92 162.4 XLON 00375482516TRLO0.1.1
26/10/2023 09:37:38 511 162.4 XLON 00375482517TRLO0.1.1
26/10/2023 11:07:50 251 161.8 XLON 00375493675TRLO0.1.1
26/10/2023 11:07:50 763 161.8 XLON 00375493676TRLO0.1.1
26/10/2023 11:07:50 148 161.6 BATE 00375493678TRLO0.1.1
26/10/2023 11:07:50 253 161.6 BATE 00375493677TRLO0.1.1
26/10/2023 11:07:50 124 161.4 AQXE 00375493679TRLO0.1.1
26/10/2023 11:07:50 113 161.4 AQXE 00375493680TRLO0.1.1
26/10/2023 11:07:50 163 161.4 AQXE 00375493681TRLO0.1.1
26/10/2023 11:07:54 142 162 CHIX 00375493682TRLO0.1.1
26/10/2023 11:08:41 232 162 CHIX 00375493741TRLO0.1.1
26/10/2023 11:52:15 188 161.8 TRQX 00375498304TRLO0.1.1
26/10/2023 11:53:53 272 161.8 CHIX 00375498463TRLO0.1.1
26/10/2023 11:53:53 58 162 CHIX 00375498464TRLO0.1.1
26/10/2023 12:02:19 382 160.8 CHIX 00375499261TRLO0.1.1
26/10/2023 12:02:19 77 161 XLON 00375499262TRLO0.1.1
26/10/2023 12:02:19 84 160.8 CHIX 00375499263TRLO0.1.1
26/10/2023 12:02:19 276 160.8 CHIX 00375499266TRLO0.1.1
26/10/2023 12:02:19 190 160.8 CHIX 00375499264TRLO0.1.1
26/10/2023 12:02:19 1444 161 XLON 00375499265TRLO0.1.1
26/10/2023 12:02:19 94 160.4 TRQX 00375499268TRLO0.1.1
26/10/2023 12:02:19 401 160.4 BATE 00375499267TRLO0.1.1
26/10/2023 12:02:19 200 159.8 AQXE 00375499269TRLO0.1.1
26/10/2023 12:02:54 3979 156.4 XLON 00375499355TRLO0.1.1
26/10/2023 12:02:54 3023 156.4 XLON 00375499354TRLO0.1.1
26/10/2023 12:05:12 507 160.2 XLON 00375499603TRLO0.1.1
26/10/2023 12:11:25 507 160.2 XLON 00375500213TRLO0.1.1
26/10/2023 12:17:23 425 160.2 XLON 00375500809TRLO0.1.1
26/10/2023 12:34:19 79 160.4 BATE 00375502282TRLO0.1.1
26/10/2023 12:55:52 92 160.4 XLON 00375504364TRLO0.1.1
26/10/2023 12:56:21 33 160.4 XLON 00375504395TRLO0.1.1
26/10/2023 13:02:12 113 159.4 BATE 00375505116TRLO0.1.1
26/10/2023 13:02:12 2525 159.4 XLON 00375505115TRLO0.1.1
26/10/2023 13:02:12 3 159.4 BATE 00375505117TRLO0.1.1
26/10/2023 13:07:40 252 159.4 BATE 00375505582TRLO0.1.1
26/10/2023 13:23:05 200 160.2 AQXE 00375507114TRLO0.1.1
26/10/2023 13:23:05 1488 160.2 XLON 00375507119TRLO0.1.1
26/10/2023 13:36:52 108 160.4 CHIX 00375508683TRLO0.1.1
26/10/2023 13:37:30 219 159.4 BATE 00375508760TRLO0.1.1
26/10/2023 13:37:30 33 159.4 BATE 00375508759TRLO0.1.1
26/10/2023 13:37:30 225 159.4 CHIX 00375508762TRLO0.1.1
26/10/2023 13:37:30 241 159.4 CHIX 00375508761TRLO0.1.1
26/10/2023 13:37:30 466 159.4 CHIX 00375508763TRLO0.1.1
26/10/2023 14:22:32 103 159.4 BATE 00375515902TRLO0.1.1
26/10/2023 14:22:32 405 159.4 BATE 00375515901TRLO0.1.1
26/10/2023 14:22:32 188 159 TRQX 00375515904TRLO0.1.1
26/10/2023 14:22:32 1014 159.4 XLON 00375515903TRLO0.1.1
26/10/2023 14:22:33 156 159.2 XLON 00375515906TRLO0.1.1
26/10/2023 14:22:33 1088 159.4 XLON 00375515907TRLO0.1.1
26/10/2023 14:29:06 183 159.6 AQXE 00375517089TRLO0.1.1
26/10/2023 14:34:49 51 158.2 XLON 00375519054TRLO0.1.1
26/10/2023 14:39:14 179 158.2 AQXE 00375521778TRLO0.1.1
26/10/2023 14:39:14 466 158.2 CHIX 00375521779TRLO0.1.1
26/10/2023 14:39:14 1470 158.2 XLON 00375521780TRLO0.1.1
26/10/2023 14:39:14 36 158.2 AQXE 00375521781TRLO0.1.1
26/10/2023 14:39:14 84 158.2 AQXE 00375521782TRLO0.1.1
26/10/2023 14:39:38 54 158 XLON 00375522100TRLO0.1.1
26/10/2023 14:39:38 228 158 XLON 00375522101TRLO0.1.1
26/10/2023 14:39:38 177 158 XLON 00375522102TRLO0.1.1
26/10/2023 14:39:38 325 158 XLON 00375522103TRLO0.1.1
26/10/2023 14:43:40 142 158 XLON 00375524742TRLO0.1.1
26/10/2023 14:43:40 177 158 XLON 00375524741TRLO0.1.1
26/10/2023 14:50:36 160 158.2 XLON 00375531701TRLO0.1.1
26/10/2023 14:50:36 351 158.2 XLON 00375531702TRLO0.1.1
26/10/2023 14:58:17 254 157.2 CHIX 00375536731TRLO0.1.1
26/10/2023 14:58:44 140 157.2 CHIX 00375536961TRLO0.1.1
26/10/2023 14:58:48 144 159.2 BATE 00375536992TRLO0.1.1
26/10/2023 15:02:00 189 157.2 CHIX 00375539651TRLO0.1.1
26/10/2023 15:02:00 51 157.2 XLON 00375539652TRLO0.1.1
26/10/2023 15:02:00 1470 157.2 XLON 00375539653TRLO0.1.1
26/10/2023 15:02:14 83 157.4 TRQX 00375539843TRLO0.1.1
26/10/2023 15:13:43 529 157 XLON 00375547500TRLO0.1.1
26/10/2023 15:34:26 1180 156 XLON 00375560781TRLO0.1.1
26/10/2023 15:34:30 146 156 BATE 00375560815TRLO0.1.1
26/10/2023 15:48:00 1521 156 XLON 00375570872TRLO0.1.1
26/10/2023 15:48:00 51 156 BATE 00375570873TRLO0.1.1
26/10/2023 15:48:00 222 156 BATE 00375570874TRLO0.1.1
26/10/2023 15:48:00 204 156 BATE 00375570876TRLO0.1.1
26/10/2023 15:48:00 131 156 CHIX 00375570875TRLO0.1.1
26/10/2023 15:48:00 220 156 BATE 00375570878TRLO0.1.1
26/10/2023 15:48:00 335 156 CHIX 00375570877TRLO0.1.1
26/10/2023 15:48:01 154 156 AQXE 00375570905TRLO0.1.1
26/10/2023 16:06:53 109 156.2 AQXE 00375582860TRLO0.1.1
26/10/2023 16:06:53 164 156.2 AQXE 00375582861TRLO0.1.1
26/10/2023 16:06:53 91 156.2 AQXE 00375582862TRLO0.1.1
26/10/2023 16:06:53 1521 156.2 XLON 00375582863TRLO0.1.1
26/10/2023 16:06:53 62 155.6 BATE 00375582864TRLO0.1.1
26/10/2023 16:06:53 107 155.6 BATE 00375582865TRLO0.1.1
26/10/2023 16:06:53 248 155.6 BATE 00375582866TRLO0.1.1
26/10/2023 16:06:53 93 155.6 BATE 00375582867TRLO0.1.1
26/10/2023 16:06:53 103 155.6 BATE 00375582868TRLO0.1.1
26/10/2023 16:06:56 302 156 XLON 00375582896TRLO0.1.1
26/10/2023 16:06:56 142 156 XLON 00375582897TRLO0.1.1
26/10/2023 16:06:56 106 156.2 XLON 00375582898TRLO0.1.1
26/10/2023 16:06:56 302 156.2 XLON 00375582899TRLO0.1.1
26/10/2023 16:06:56 665 156.2 XLON 00375582900TRLO0.1.1
26/10/2023 16:08:00 507 156 XLON 00375583572TRLO0.1.1
26/10/2023 16:11:34 7 156.4 TRQX 00375585749TRLO0.1.1
26/10/2023 16:12:33 3 156.4 TRQX 00375586270TRLO0.1.1
26/10/2023 16:13:59 3 156.4 TRQX 00375587135TRLO0.1.1
26/10/2023 16:15:04 5 156.4 TRQX 00375587851TRLO0.1.1
26/10/2023 16:15:29 832 155.6 XLON 00375588142TRLO0.1.1
26/10/2023 16:16:17 3 156.4 TRQX 00375588790TRLO0.1.1
26/10/2023 16:17:29 3 156.4 TRQX 00375589610TRLO0.1.1
26/10/2023 16:18:34 3 156.4 TRQX 00375590223TRLO0.1.1
26/10/2023 16:18:55 3 155.6 CHIX 00375590440TRLO0.1.1
26/10/2023 16:21:08 6 156.4 TRQX 00375591994TRLO0.1.1
26/10/2023 16:21:28 140 155.6 CHIX 00375592125TRLO0.1.1
26/10/2023 16:21:51 142 155.6 CHIX 00375592408TRLO0.1.1
26/10/2023 16:24:50 4 156.2 TRQX 00375594455TRLO0.1.1
26/10/2023 16:24:55 98 155.6 CHIX 00375594503TRLO0.1.1
26/10/2023 16:26:40 83 155.6 CHIX 00375595761TRLO0.1.1
26/10/2023 16:26:40 4 155.6 BATE 00375595762TRLO0.1.1
26/10/2023 16:26:40 2 155.6 CHIX 00375595763TRLO0.1.1
26/10/2023 16:26:40 1040 155.6 XLON 00375595764TRLO0.1.1
26/10/2023 16:29:35 256 156.2 TRQX 00375597693TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFFDIILRFIVRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement